Cryotherapy for hepatocellular carcinoma

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2009, Pages

  Awad, Tahany ^a   Thorlund, Kristian ^a   Gluud, Christian ^a  

^a Mental Health Services CPH   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

CLINICAL EVALUATION; CLINICAL TRIAL; COHORT ANALYSIS; CRYOSURGERY; CRYOTHERAPY; DISEASE FREE SURVIVAL; HUMAN; LIVER CELL CARCINOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; SENSITIVITY ANALYSIS; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; CATHETER ABLATION; LIVER TUMOR; METHODOLOGY; RETROSPECTIVE STUDY; CHEMOEMBOLIZATION; INTERMETHOD COMPARISON; RADIOFREQUENCY ABLATION;

CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CRYOTHERAPY; HUMANS; LIVER NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 70049095224     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007611     Document Type: Review

References (42)

1. Aguilar F, Hussain S, Cerutti P. Aflatoxin B1 induces the transversion of G - >T in codon 249 of the p53 tumor suppressor gene in human hepatocytes. Proceedings of the National Academy of Sciences of the United States of America 1993;90(18):8586-8590 (Pubitemid 23277714)
2. Bosch FX, Ribes J, Diaz M, Clqries R. Primary liver cancer: Worldwide incidence and trends. Gastroenterology 2004;127(5):S5-S16. (Pubitemid 39423365)
3. Bradburn MJ, Deeks JJ, Berlin JA, Localio AR. Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events. Statistics in Medicine 2006;26(1):53-77.
4. Brok J, Thorlund K, Gluud C, Wetterslev J. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. Journal of Clinical Epidemiology 2008;61(8):763-769
5. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; Vol.42, issue 5:1208-1236
6. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al.Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference. Journal of Hepatology 2001;35:421-430 (Pubitemid 32844200)
7. Charnley RM, Doran J, Morris DL. Cryotherapy for liver colorectal metastases: A new approach. British Journal of Surgery 1989;76:1040-1041 (Pubitemid 19251499)
8. DeMets DL. Methods of combining randomized clinical trials: strengths and limitations. Statistics in Medicine 1987;6(3):341-350
9. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177-188
10. Deuffic S, Poynard T, Buffat L, Valleron A-J. Trends in primary liver cancer. The Lancet 1998;351(9097):214-215
11. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315(7109):629-634 (Pubitemid 27387172)
12. El-Serag HB, Davila JA, Petersen NJ, McGlynn KA. The continuing increase in the Incidence of hepatocellular carcinoma in the United States: An update. Ann Intern Med 2003;139(10):817-823
13. Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 2004;127(5 Suppl 1):S35-50. (Pubitemid 39423368)
14. Gluud C, Nikolova D, Klingenberg SL, Whitfield K, Alexakis N, Als-Nielsen B, et al.Cochrane Hepato-Biliary Group. About The Cochrane Collaboration: Cochrane Review Groups (CRGs). John Wiley & Sons, Ltd, 2008, issue 3.
15. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002;21(11):1539-1558
16. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0. The Cochran Collaboration, 2008. Available from www.cochrane-handbook.org, [updated February 2008].
17. International Conference on Harmonisation Expert Working Group. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice1997 CFR & ICH Guidelines. Vol. 1, PA 19063-2043, USA: Barnett International/PAREXEL, 1997:1.
18. Kjaergard LL, Villumsen J, Gluud C. Reported methodological quality and discrepancies between small and large randomized trials in meta-analyses. Annals of Internal Medicine 2001;135(11):982-989 (Pubitemid 33131619)
19. Kohli V, Clavien PA. Cryoablation of liver tumors. British Journal of Surgery 1998;85:1171-1172
20. Kumar M, Kumar R, Hissar SS, Saraswat MK, Sharma BC, Sakhuja P, et al.Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India. Journal of Gastroenterology and Hepatology 2007;22(7):1104-1111 (Pubitemid 47019860)
21. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. The Lancet 2003/12/6;362(9399):1907-1917
22. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al.Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?. Lancet 1998;352:609-613 (Pubitemid 28380142)
23. Onik G, Rubinsky B, Zemel R, Weaver L, Diamond D, Cobb C, et al.Ultrasound-guided hepatic cryosurgery in the treatment of colorectal metastatic colon carcinoma. Preliminary results. Cancer 1991;67:901-907
24. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA 2005;55(2):74-108.
25. Pearson AS, Izzo F, Fleming RY, Ellis LM, Delrio P, Roh MS, et al.Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. The American Journal of Surgery 1999;178(6):592-598 (Pubitemid 30058318)
26. Preketes AP, Caplehorn JRM, King J, Clingan PR, Ross WB, Morris DL. Effect of hepatic artery chemotherapy on survival of patients with hepatic metastases from colorectal carcinoma treated with cryotherapy. The World Journal of Surgery 1995;19:768-771
27. Ravikumar TJ, Kane R, Cady B, Jenkins RL, McDermott W, Onik G, et al.Hepatic cryosurgery with intraoperative ultrasound monitoring for metastatic colon carcinoma. Archives of Surgery 1987;122:403-409 (Pubitemid 17051864)
28. Regan LS. Screening for hepatocellular carcinoma in high-risk individuals: A clinical review. Archives of Internal Medicine 1989;149(8):1741-1744
29. Royle P, Milne R. Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches. International Journal of Technology Assessment in Health Care 2003;19(4):591-603. (Pubitemid 38405633)
30. Rücker G, Schwarzer G, Carpenter J. Arcsine test for publication bias in meta-analyses with binary outcomes. Statistics in Medicine 2008;27:746-763 (Pubitemid 351278817)
31. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions ofmethodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408-412
32. Schwartz M, Roayaie S, Konstadoulakis M. Strategies for the management of hepatocellular carcinoma. Nature Clinical Practice Oncology 2007;4:424-432
33. Seifert JK, Morris DL.World Survey on the complications of hepatic and prostate cryotherapy. World Journal of Surgery 1999;23:109-114
34. Shafir M, Shapiro R, Sung M, Warner R, Sicular A, Klipfel A.Cryoablation of unresectable malignant liver tumors. American Journal of Surgery 1996;171:27-31. (Pubitemid 26028188)
35. Stroffolini T, Andreone P, Andriulli A, Ascione A, Craxi A, Chiaramonte M, et al.Characteristics of hepatocellular carcinoma in Italy. Journal of Hepatology 1998;29(6):944-952
36. Taylor-Robinson SD, Foster GR, Arora S, Hargreaves S, Thomas HC. Increase in primary liver cancer in the UK, 1979-1994. The Lancet 1997;350(9085):1142- 1143
37. Tiribelli C, Melato M, Croce LS, Giarelli L, Okuda K, Ohnishi K. Prevalence of hepatocellular carcinoma and relation to cirrhosis: comparison of two different cities of the world - Trieste, Italy, and Chiba, Japan. Hepatology 1989;10(6):998-1002. (Pubitemid 20341090)
38. Weaver ML, Atkinson D, Zemel R. Hepatic cryosurgery in treating colorectal metastases. Cancer 1995;76:210-214 (Pubitemid 26039787)
39. Wetterslev J, Thorlund K, Brok J, Gluud C. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. Journal of Clinical Epidemiology 2008;61(1):64-75. (Pubitemid 350245732)
40. Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman GD, et al.Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ 2008;336:601-605
41. Yeh F, Yu M, Mo C, Luo S, Tong M, Henderson B. Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. Cancer Research 1989;49:2506-2509 (Pubitemid 19125586)
42. Zhou XD, Tang ZY, Yu YQ, Ma ZC. Clinical evaluation of cryosurgery in the treatment of primary liver cancer. Report of 60 cases. Cancer 1988;61:1889-1892 (Pubitemid 18112773)